Efficacy of venlafaxine and fluoxetine inpatients with major depressive disorder and co-morbid generalized anxiety disorder

被引：0
|
作者：
Silverstone, PH
Salinas, EO
机构：
[1] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada
[2] Wyeth Ayerst Res, Radnor, PA USA
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [1] Insomnia severity in patients with primary insomnia and insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Roth, Thomas
    Wilson, Phebe
    Schaefer, Kendyl
    Pfleeger, Kimberly
    Rubens, Robert
    Fava, Maurizio
    Pollack, Mark
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 85S
  • [2] Venlafaxine XR versus fluoxetine in the treatment of major depressive disorder and generalized anxiety disorder dual diagnosis
    Vasile, D.
    Vasiliu, O.
    Ivanov, P.
    Ojog, D.
    Sarmache, M.
    Vasile, M.
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 : S247 - S247
  • [3] Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder
    Silverstone, PH
    Salinas, E
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (07) : 523 - 529
  • [4] Genome wide association scan of co-morbid anxiety in major depressive disorder (MDD)
    Schosser, A.
    Ng, M. Y.
    Butler, A. W.
    Uher, R.
    Cohen-Woods, S.
    Craddock, N.
    Owen, M.
    Aitchison, K. J.
    Breen, G.
    Craig, I.
    Farmer, A. E.
    Lewis, C. M.
    McGuffin, P.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2010, 14 : 37 - 37
  • [5] Venlafaxine in depressive disorder comorbid with generalized anxiety disorder
    Kulenovic, A. Dzubur
    Kucukalic, A.
    Bravo-Mehmedbasic, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S466 - S467
  • [6] Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: Prevalence of painful somatic symptoms, functioning and health status
    Romera, Irene
    Fernandez-Perez, Sabela
    Luis Montejo, Angel
    Caballero, Fernando
    Caballero, Luis
    Angel Arbesu, Jose
    Delgado-Cohen, Helena
    Desaiah, Durisala
    Polavieja, Pepa
    Gilaberte, Inmaculada
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2010, 127 (1-3) : 160 - 168
  • [7] Evaluation of the HAM-D17 following eszopiclone treatment in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Montgomery, S.
    Fava, M.
    Krystal, A.
    Wessel, T.
    Amato, D.
    Cooper, J.
    McCall, W. V.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 306 - 306
  • [8] Evaluation of the HAM-D17 following eszopiclone treatment in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Fava, M.
    Pollack, M.
    Montgomery, S.
    Wessel, T.
    Amato, D.
    Krystal, A.
    Hayduk, R.
    McCall, W. V.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S360 - S360
  • [9] Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study
    Almeida, Susana S.
    Christensen, Michael Cronquist
    Simonsen, Kenneth
    Adair, Michael
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (03) : 279 - 288
  • [10] Evaluation of the Hamilton depression scale following eszopiclone treatment for insomnia in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Fava, Maurizio
    Pollack, Mark
    Rubens, Robert
    Amato, David
    Krystal, Andrew
    Hayduk, Roza
    McCall, W. Vaughn
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 84S
12345